This comprehensive resource covers the current thoughts and trends on narcolepsy, as well as cutting-edge evidence-based research. Updates from the previous edition include advances in diagnostic guidelines, treatments, protocols and clinical and psychosocial considerations. Aspects of narcolepsy relating to sleep medicine, neurology, psychiatry and public health are featured throughout the text. Narcolepsy, 2nd Edition provides clinicians and allied health professionals with patient management modalities, clinical and quality of life issues and best practices for health care delivery.
This comprehensive resource covers the current thoughts and trends on narcolepsy, as well as cutting-edge evidence-based research. Updates from the previous edition include advances in diagnostic guidelines, treatments, protocols and clinical and psychosocial considerations. Aspects of narcolepsy relating to sleep medicine, neurology, psychiatry and public health are featured throughout the text. Narcolepsy, 2nd Edition provides clinicians and allied health professionals with patient management modalities, clinical and quality of life issues and best practices for health care delivery.
Meeta Goswami, BDS, MPH, PhD, Director, Narcolepsy Institute, Montefiore Medical Center, Assistant Professor, Albert Einstein College of Medicine, Department of Neurology, Bronx, New York, USA Michael J. Thorpy, MD, Director, Sleep-Wake Disorders Center, Montefiore Medical Center, Professor of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA and S. R. Pandi-Perumal, Somnpogen Canada Inc, Toronto, Ontario, Canada
Inhaltsangabe
Section I--Etiology.- 1. The Genetics of Narcolepsy.- 2. Orexin (Hypocretin) and Narcolepsy.- 3. Precipitants of Narcolepsy: Vaccines and Infections.- Section II--Clinical Considerations.- 4. Epidemiology of Narcolepsy.- 5. Diagnostic Criteria and Delay in Diagnosis of Narcolepsy.- 6. Narcolepsy in Childhood.- 7. Narcolepsy in the Older Adult.- 8. Hypnagogic Hallucinations and Sleep Paralysis.- 9. Symptomatic Narcolepsy or Hypersomnia, with and without Hypocretin (Orexin) Deficiency.- 10. Hypersomnias Other than Narcolepsy: Differential Diagnosis.- 11. Narcolepsy and Other Comorbid Medical Illnesses.- 12. Sleep Disorders Comorbidities in Narcolepsy and their Management.- 13. Neuroimaging of Narcolepsy.- Section III--Psychosocial Considerations.- 14. Quality of Life and Psychosocial Issues in Narcolepsy: Implications for Management.- 15. Narcolepsy, Intimacy and Sexuality.- 16. Memory and Cognition in Narcolepsy.- 17. Psychoanalysis and Narcolepsy.- 18. Dreaming in Narcolepsy.- 19. Narcolepsy and Mental Illness.- 20. Narcolepsy, Driving and Traffic Safety.- Section IV--Management.- 21. Overview of Management of Narcolepsy.- 22. Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics.- 23. Modafinil/Armodafinil in the Treatment of Narcolepsy.- 24. Sodium Oxybate in the Treatment of Narcolepsy.- 25. Pregnancy and Anaesthesia in Narcolepsy.- 26. Emerging Treatments for Narcolepsy.- 27. Behavioral and Non-Pharmacological Management of Narcolepsy.- Section V--Health Care Delivery and Medico-Legal Considerations.- 28. Narcolepsy and Developmental Disability.- 29. Succeeding in School and in the Workplace with Narcolepsy.- 30. Medico-Legal Aspects of Disability in Narcolepsy.- 31. The Affordable Care Act and the Future of Sleep Medicine.
Section I--Etiology.- 1. The Genetics of Narcolepsy.- 2. Orexin (Hypocretin) and Narcolepsy.- 3. Precipitants of Narcolepsy: Vaccines and Infections.- Section II--Clinical Considerations.- 4. Epidemiology of Narcolepsy.- 5. Diagnostic Criteria and Delay in Diagnosis of Narcolepsy.- 6. Narcolepsy in Childhood.- 7. Narcolepsy in the Older Adult.- 8. Hypnagogic Hallucinations and Sleep Paralysis.- 9. Symptomatic Narcolepsy or Hypersomnia, with and without Hypocretin (Orexin) Deficiency.- 10. Hypersomnias Other than Narcolepsy: Differential Diagnosis.- 11. Narcolepsy and Other Comorbid Medical Illnesses.- 12. Sleep Disorders Comorbidities in Narcolepsy and their Management.- 13. Neuroimaging of Narcolepsy.- Section III--Psychosocial Considerations.- 14. Quality of Life and Psychosocial Issues in Narcolepsy: Implications for Management.- 15. Narcolepsy, Intimacy and Sexuality.- 16. Memory and Cognition in Narcolepsy.- 17. Psychoanalysis and Narcolepsy.- 18. Dreaming in Narcolepsy.- 19. Narcolepsy and Mental Illness.- 20. Narcolepsy, Driving and Traffic Safety.- Section IV--Management.- 21. Overview of Management of Narcolepsy.- 22. Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics.- 23. Modafinil/Armodafinil in the Treatment of Narcolepsy.- 24. Sodium Oxybate in the Treatment of Narcolepsy.- 25. Pregnancy and Anaesthesia in Narcolepsy.- 26. Emerging Treatments for Narcolepsy.- 27. Behavioral and Non-Pharmacological Management of Narcolepsy.- Section V--Health Care Delivery and Medico-Legal Considerations.- 28. Narcolepsy and Developmental Disability.- 29. Succeeding in School and in the Workplace with Narcolepsy.- 30. Medico-Legal Aspects of Disability in Narcolepsy.- 31. The Affordable Care Act and the Future of Sleep Medicine.
Section I--Etiology.- 1. The Genetics of Narcolepsy.- 2. Orexin (Hypocretin) and Narcolepsy.- 3. Precipitants of Narcolepsy: Vaccines and Infections.- Section II--Clinical Considerations.- 4. Epidemiology of Narcolepsy.- 5. Diagnostic Criteria and Delay in Diagnosis of Narcolepsy.- 6. Narcolepsy in Childhood.- 7. Narcolepsy in the Older Adult.- 8. Hypnagogic Hallucinations and Sleep Paralysis.- 9. Symptomatic Narcolepsy or Hypersomnia, with and without Hypocretin (Orexin) Deficiency.- 10. Hypersomnias Other than Narcolepsy: Differential Diagnosis.- 11. Narcolepsy and Other Comorbid Medical Illnesses.- 12. Sleep Disorders Comorbidities in Narcolepsy and their Management.- 13. Neuroimaging of Narcolepsy.- Section III--Psychosocial Considerations.- 14. Quality of Life and Psychosocial Issues in Narcolepsy: Implications for Management.- 15. Narcolepsy, Intimacy and Sexuality.- 16. Memory and Cognition in Narcolepsy.- 17. Psychoanalysis and Narcolepsy.- 18. Dreaming in Narcolepsy.- 19. Narcolepsy and Mental Illness.- 20. Narcolepsy, Driving and Traffic Safety.- Section IV--Management.- 21. Overview of Management of Narcolepsy.- 22. Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics.- 23. Modafinil/Armodafinil in the Treatment of Narcolepsy.- 24. Sodium Oxybate in the Treatment of Narcolepsy.- 25. Pregnancy and Anaesthesia in Narcolepsy.- 26. Emerging Treatments for Narcolepsy.- 27. Behavioral and Non-Pharmacological Management of Narcolepsy.- Section V--Health Care Delivery and Medico-Legal Considerations.- 28. Narcolepsy and Developmental Disability.- 29. Succeeding in School and in the Workplace with Narcolepsy.- 30. Medico-Legal Aspects of Disability in Narcolepsy.- 31. The Affordable Care Act and the Future of Sleep Medicine.
Section I--Etiology.- 1. The Genetics of Narcolepsy.- 2. Orexin (Hypocretin) and Narcolepsy.- 3. Precipitants of Narcolepsy: Vaccines and Infections.- Section II--Clinical Considerations.- 4. Epidemiology of Narcolepsy.- 5. Diagnostic Criteria and Delay in Diagnosis of Narcolepsy.- 6. Narcolepsy in Childhood.- 7. Narcolepsy in the Older Adult.- 8. Hypnagogic Hallucinations and Sleep Paralysis.- 9. Symptomatic Narcolepsy or Hypersomnia, with and without Hypocretin (Orexin) Deficiency.- 10. Hypersomnias Other than Narcolepsy: Differential Diagnosis.- 11. Narcolepsy and Other Comorbid Medical Illnesses.- 12. Sleep Disorders Comorbidities in Narcolepsy and their Management.- 13. Neuroimaging of Narcolepsy.- Section III--Psychosocial Considerations.- 14. Quality of Life and Psychosocial Issues in Narcolepsy: Implications for Management.- 15. Narcolepsy, Intimacy and Sexuality.- 16. Memory and Cognition in Narcolepsy.- 17. Psychoanalysis and Narcolepsy.- 18. Dreaming in Narcolepsy.- 19. Narcolepsy and Mental Illness.- 20. Narcolepsy, Driving and Traffic Safety.- Section IV--Management.- 21. Overview of Management of Narcolepsy.- 22. Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics.- 23. Modafinil/Armodafinil in the Treatment of Narcolepsy.- 24. Sodium Oxybate in the Treatment of Narcolepsy.- 25. Pregnancy and Anaesthesia in Narcolepsy.- 26. Emerging Treatments for Narcolepsy.- 27. Behavioral and Non-Pharmacological Management of Narcolepsy.- Section V--Health Care Delivery and Medico-Legal Considerations.- 28. Narcolepsy and Developmental Disability.- 29. Succeeding in School and in the Workplace with Narcolepsy.- 30. Medico-Legal Aspects of Disability in Narcolepsy.- 31. The Affordable Care Act and the Future of Sleep Medicine.
Rezensionen
"The purpose is to present the current understanding of the etiology, presentation, and treatment of narcolepsy. ... This book will benefit primary care physicians, sleep professionals, neurologists, psychiatrists, and pediatricians, as well as psychologists, social scientists, and nurses. It will be of interest to anyone involved in research or caring for this patient population. ... This is a thorough, in-depth reference with up-to-date information on the etiology, presentation, psychosocial complications, and treatment of this illness." (Michael Easton, Doody's Book Reviews, July, 2016)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
